Bengaluru, July 27 -- Bengaluru: Tata 1mg's core healthcare business continued to grow and narrowed losses in 2025-26 even as its technology arm saw a sharp decline in profitability.

Tata 1mg Healthcare Solutions Pvt. Ltd reported a turnover of Rs.2,439.8 crore for fiscal year 2026 (FY26), up 21% from Rs.2,016.5 crore a year ago. Its net loss narrowed marginally to Rs.310 crore from Rs.341.8 crore, according to the annual report of Tata Sons, the Tata group's investment holding company.

Tata 1mg Technologies Pvt. Ltd reported a turnover of Rs.496.1 crore, up 32% from Rs.375.5 crore a year ago. However, profit after tax dropped sharply to Rs.17.5 crore from Rs.65.4 crore. Tata Sons' investment in Tata 1mg Technologies stood at Rs.1,335 c...